Back to Neurology

OUR EXPERTISE AND AND SERVICES AVAILABLE IN

Emerging Neurology

Overview

Spherix’s coverage of emerging neurology indications focuses on evolving markets where a paradigm shift is expected in the coming years.

Services Available

Prepping for the pipeline

  • Alzheimer's Disease (US)

  • Amyotrophic Lateral Sclerosis (US)

  • Neuromyelitis Optica Spectrum Disorder (US)

  • Myasthenia Gravis (US)

Benchmarking new brand performance

  • Aduhelm (Biogen) in Alzheimer's Disease (US)

  • Donanemab (Eli Lilly) in Alzheimer’s Disease (US)*

  • Lecanemab (Eisai/Biogen) in Alzheimer’s Disease (US)*

*Pending approvals and launch

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Emerging Neurology Coverage